We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$2.45B
AUM Growth
+$190M
Cap. Flow
-$50.3M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.35%
Holding
310
New
106
Increased
57
Reduced
61
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 20.08%
2 Financials 17.24%
3 Consumer Discretionary 15.54%
4 Industrials 14.09%
5 Technology 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHTH icon
51
eHealth
EHTH
$45.1M
$16.8M 0.69%
175,151
-23,350
-12% -$1.81M
ZGNX
52
DELISTED
Zogenix, Inc.
ZGNX
$16.4M 0.67%
314,169
-16,000
-5% -$733K
TRHC
53
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$15.9M 0.65%
327,624
+1,623
+0.5% +$76K
COLL icon
54
Collegium Pharmaceutical
COLL
$1.16B
$15.7M 0.64%
+764,912
New +$12.7M
MNTV
55
DELISTED
Momentive Global Inc. Common Stock
MNTV
$15.6M 0.64%
872,945
LIVN icon
56
LivaNova
LIVN
$4.69B
$15.4M 0.63%
204,769
+49,722
+32% +$3.77M
MC icon
57
Moelis & Co
MC
$5.09B
$15.4M 0.63%
481,800
-20,761
-4% -$680K
RDUS
58
DELISTED
Radius Health, Inc.
RDUS
$15.4M 0.63%
762,173
TDOC icon
59
Teladoc Health
TDOC
$1.22B
$15.3M 0.62%
182,695
-159,404
-47% -$12.1M
GLUU
60
DELISTED
Glu Mobile Inc.
GLUU
$15.1M 0.62%
2,493,631
+644
+0% +$3.68K
AX icon
61
Axos Financial
AX
$5.96B
$14.9M 0.61%
+492,070
New +$14.4M
INSM icon
62
Insmed
INSM
$21.4B
$14.7M 0.6%
617,373
-294,563
-32% -$5.99M
BWIN
63
Baldwin Insurance Group
BWIN
$2.79B
$14.7M 0.6%
+917,203
New +$14.6M
QTWO icon
64
Q2 Holdings
QTWO
$3.99B
$14.6M 0.6%
179,839
DRNA
65
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14.6M 0.59%
661,052
-117,464
-15% -$2.36M
PLMR icon
66
Palomar
PLMR
$3.61B
$14.3M 0.59%
284,039
+262,959
+1,247% +$12.3M
PLCE icon
67
Children's Place
PLCE
$59.2M
$14.1M 0.58%
226,127
-45,613
-17% -$3.33M
MTSI icon
68
MACOM Technology Solutions
MTSI
$20.9B
$14.1M 0.58%
+530,445
New +$12.7M
ATRC icon
69
AtriCure
ATRC
$1.98B
$14.1M 0.58%
433,912
TMHC
70
DELISTED
Taylor Morrison
TMHC
$13.8M 0.56%
630,640
+422,690
+203% +$10.2M
SAM icon
71
Boston Beer
SAM
$1.92B
$13.4M 0.55%
35,406
+23,324
+193% +$8.78M
NVEE
72
DELISTED
NV5 Global
NVEE
$13.1M 0.53%
1,037,744
+1,700
+0.2% +$24.8K
OLLI icon
73
Ollie's Bargain Outlet
OLLI
$4.66B
$13.1M 0.53%
200,023
-144,756
-42% -$9.17M
TECX
74
Tectonic Therapeutic
TECX
$550M
$12.9M 0.53%
53,449
+10
+0% +$1.93K
ABCB icon
75
Ameris Bancorp
ABCB
$6B
$12.8M 0.52%
300,100
+217,779
+265% +$9.3M

Similar funds

Emerald Mutual Fund Advisers Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Mutual Fund Advisers Trust held 310 positions worth $2.45B, up 8.4% from $2.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2019 filing shows 106 new, 57 increased, 61 reduced and 23 closed positions. Its largest new stake was BellRing Brands: 1,572,144 shares worth $33.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2019 buy was BellRing Brands: 1,572,144 shares worth $33.5M.
  • Emerald Mutual Fund Advisers Trust added most to Perficient Inc in Q4 2019, an estimated $14.6M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $30.9M.
  • Emerald Mutual Fund Advisers Trust fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $12.9M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $2.45B portfolio in Q4 2019.
  • Emerald Mutual Fund Advisers Trust opened 106 new positions and closed 23 in Q4 2019.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 8.4% quarter-over-quarter to $2.45B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.